Drug Trial Radar · NCT01436500
Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
Last checked: Nov 19, 2026Latest source record: Mar 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
55
Actual
Start
Oct 2011
Primary completion
Jun 2015
Study completion Jul 2015
Sponsor
- Lead sponsor
- Cumberland PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Sep 19, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study of ifetroban in the treatment of hepatorenal syndrome (HRS) in hospitalized adult patients to assess the safety and pharmacokinetics of 3 days of intravenous ifetroban.
Conditions
- Hepatorenal Syndrome
Interventions
Ifetroban InjectionDrug
Ifetroban sodium injectable, diluted in sterile water with 5% dextrose
PlaceboDrug
Sterile water with 5% Dextrose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Half-life (T-1/2) of Ifetroban and Ifetroban AcylglucuronideTime frame: 3 days
- Pharmacokinetic Parameters (Exposure) of Ifetroban and Ifetroban Acylglucuronide After Three Days of TreatmentTime frame: 3 days
- Pharmacokinetic Parameters (Concentration) of Ifetroban and Ifetroban Acylglucuronide After Three Days of TreatmentTime frame: 3 days
Locations
12 sites in 2 countries. Site status is shown where the registry gives one.
Mayo Clinic - Arizona
Phoenix, Arizona
UCSD, Hillcrest Medical Center Hospital
La Jolla, California
UCSF (University of California-San Francisco)
San Francisco, California
Emory University Hospital
Atlanta, Georgia
Indiana University (Division of Gastroenterology/Hepatology)
Indianapolis, Indiana
University of Michigan Hospital
Ann Arbor, Michigan
NYU Langone Medical Center
New York, New York
The Ohio State University
Columbus, Ohio
Baylor All Saints Medical Center
Fort Worth, Texas
University of Utah Health Sciences Center
Salt Lake City, Utah
Virginia Commonwealth University
Richmond, Virginia
MIDAS Multispeciality Hospital PVT LTD
Nagpur, Maharashtra, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.